Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes

BACKGROUND: First-line therapy for treatment of advanced urothelial carcinoma includes combination platinum-based chemotherapies, though resistance and long-term toxicity concerns to these regimens cause limitations in progression-free survival and overall survival. Maintenance treatment with an alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Ten Eyck, Jennifer E, Kahlon, Navkirat, Masih, Sonia, Hamouda, Danae M, Petros, Firas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882657/
https://www.ncbi.nlm.nih.gov/pubmed/35237074
http://dx.doi.org/10.2147/CMAR.S227323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882657/
https://www.ncbi.nlm.nih.gov/pubmed/35237074
http://dx.doi.org/10.2147/CMAR.S227323

Ejemplares similares